Your browser doesn't support javascript.
loading
Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study.
Takahashi, Hiromichi; Miura, Katsuhiro; Nakagawa, Masaru; Nishimaki, Haruna; Ito, Shun; Nukariya, Hironao; Kurihara, Kazuya; Endo, Toshihide; Koike, Takashi; Hamada, Takashi; Iizuka, Kazuhide; Ohatake, Shimon; Iriyama, Noriyoshi; Nakayama, Tomohiro; Masuda, Shinobu; Hatta, Yoshihiro; Nakamura, Hideki.
Affiliation
  • Takahashi H; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Miura K; Department of Pathology and Microbiology, Division of Laboratory Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Nakagawa M; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Nishimaki H; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Ito S; Department of Pathology and Microbiology, Division of Oncologic Pathology, Nihon University School of Medicine, Tokyo, Japan.
  • Nukariya H; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Kurihara K; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Endo T; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Koike T; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Hamada T; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Iizuka K; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Ohatake S; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Iriyama N; Department of Pathology and Microbiology, Division of Laboratory Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Nakayama T; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Masuda S; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Hatta Y; Department of Pathology and Microbiology, Division of Laboratory Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Nakamura H; Department of Pathology and Microbiology, Division of Oncologic Pathology, Nihon University School of Medicine, Tokyo, Japan.
Hematol Oncol ; 40(5): 1094-1096, 2022 12.
Article in En | MEDLINE | ID: mdl-35781821
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral Limits: Humans Language: En Journal: Hematol Oncol Year: 2022 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral Limits: Humans Language: En Journal: Hematol Oncol Year: 2022 Type: Article Affiliation country: Japan